Article
Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) - 1 Jan 2000
van Den Brink M R, Moore E, Horndasch K J, Crawford J M, Hoffman J, Murphy G F, Burakoff S J
Abstract excerpt
The Fas/Fas ligand (FasL) pathway is involved in a variety of regulatory mechanisms that could be important for the development of graft-vs-host disease (GVHD) after bone marrow transplantation (BMT), such as cytolysis of target cells by cytotoxic T cells, regulation of inflammatory responses, peripheral deletion of autoimmune cells, costimulation of T cells, and activation-induced cell death. To further evaluate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
